OrthoPediatrics Corp.
NASDAQ:KIDSMedical - Devices
+$0.19 today
- Market cap
- $826.40M
- Beta
- 1.01
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$1.68
Volume 0.16M
Average 0.16M
KIDS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
OrthoPediatrics Corp.NASDAQ: KIDS
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 57.4% from a year ago
Cash & equivalents stood at $14.25M at the end of Q1 FY2026, down 57.4% from a year earlier and down 27.2% from the prior quarter. Over 3 fiscal years it compounded at +29.6% a year.
Context
- Cash & equivalents amounted to 2.8% of total assets at the end of Q1 FY2026, down 4.3 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -57.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 19.56M USD
- Year-over-year change
- -55.4%
- 4-year CAGR
- +21.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.56M | -55.4% |
| FY2024 | 2024-12-31 | 43.82M | +41.1% |
| FY2023 | 2023-12-31 | 31.06M | +245.4% |
| FY2022 | 2022-12-31 | 8.99M | -0.2% |
| FY2021 | 2021-12-31 | 9.01M | — |
Cash & Equivalents vs competitors
How KIDS compares with its peers on the latest reported figures
- KIDS's Mar 2026 cash & equivalents of $14.25M is the 7th highest of the 8 companies compared; the peer median is $35.85M.
- Its year-over-year change of -57.4% is the 7th highest of 8, against a peer median of -26.7%.
- Cash & equivalents amounts to 2.8% of total assets for KIDS, versus a peer median of 18.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $265.77M | +76.1% | +13.3% | 41.6% | |
| Mar 2026 | $49.79M | -26.7% | -0.1% | 22.6% | |
CBLLCeriBell, Inc. | Mar 2026 | $45.25M | -70.5% | -16.0% | 25.4% |
| Mar 2026 | $35.85M | +57.2% | +19.3% | 5.5% | |
| Mar 2026 | $30.28M | -23.8% | +33.8% | 18.0% | |
| Mar 2026 | $17.57M | -37.2% | +19.0% | 5.8% | |
| Mar 2026 | $14.25M | -57.4% | +29.6% | 2.8% | |
| Mar 2026 | $9.54M | -28.6% | -18.1% | 5.2% | |
| Peer median (excluding KIDS) | $35.85M | -26.7% | +13.3% | 18.0% | |
Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 9.01M | 8.99M | 31.06M | 43.82M | 19.56M |
| Short-term Investments | 45.9M | 109.3M | 49.25M | 25.01M | 41.3M |
| Net Receivables | 17.94M | 24.8M | 34.62M | 42.36M | 53.84M |
| Inventory | 57.57M | 78.19M | 105.85M | 117.01M | 133.79M |
| Other Current Assets | 3.23M | 1.47M | 5.72M | 1.96M | 7.94M |
| Total Current Assets | 133.65M | 226.72M | 226.5M | 237.17M | 256.42M |
| Property, Plant & Equipment (Net) | 28.52M | 34.29M | 41.05M | 58.83M | 49.56M |
| Goodwill | 72.35M | 86.82M | 83.7M | 93.84M | 109.27M |
| Intangible Assets | 69.76M | 79.9M | 84.56M | 81.18M | 77.71M |
| Long-term Investments | 0 | 189.52M | 1.86M | 2.18M | 0 |
| Tax Assets | 4.13M | 5.95M | 0 | 0 | 0 |
| Other Non-current Assets | 0 | (195.48M) | 1.09M | 0 | 15.68M |
| Total Non-current Assets | 174.75M | 201.01M | 212.25M | 236.04M | 252.21M |
| Total Assets | 308.4M | 427.73M | 438.75M | 473.21M | 508.63M |
| Account Payables | 9.33M | 11.15M | 12.65M | 8.91M | 18.79M |
| Short-term Debt | 13M | 144K | 152K | 160K | 170K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 5.95M | 0 | 0 | 0 |
| Other Current Liabilities | 2.04M | 6.88M | 7.39M | 8.89M | 16.64M |
| Total Current Liabilities | 29.72M | 30.87M | 41.67M | 33.96M | 46.2M |
| Long-term Debt | 15.22M | 763K | 9.91M | 72.96M | 99.82M |
| Deferred Tax Liabilities | 8.9M | 5.95M | 5.48M | 0 | 3.58M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 28.91M | 11.49M | 4.66M | 6.06M | 12.44M |
| Total Non-current Liabilities | 53.32M | 18.21M | 20.05M | 84.68M | 115.84M |
| Total Liabilities | 83.03M | 49.08M | 61.72M | 118.64M | 162.03M |
| Common Stock | 5K | 6K | 6K | 6K | 6K |
| Retained Earnings | (178.03M) | (176.77M) | (197.74M) | (235.56M) | (275.21M) |
| Accumulated OCI | 8.49M | (5.4M) | (5.53M) | (10.77M) | (523K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 225.37M | 378.65M | 377.03M | 354.57M | 346.6M |
| Total Debt | 28.51M | 907K | 10.06M | 80.9M | 99.99M |
| Net Debt | 19.5M | (8.08M) | (21M) | 37.08M | 80.43M |
OrthoPediatrics Corp.
NASDAQ:KIDS
Intrinsic Alpha fair value
Locked
Current Price
$31.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.